Work

In Brief: Omlyclo — An Omalizumab Biosimilar Interchangeable with Xolair

Year: 2025

Type: article

Source: The medical letter on drugs and therapeutics/The medical letter

DOI: 10.58347/tml.2025.1730f

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4411009273

FWCI:

Cites:

Cited by:

Related to: 10